Zhou‐Yan Bian

2.6k total citations
63 papers, 2.2k citations indexed

About

Zhou‐Yan Bian is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Zhou‐Yan Bian has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 33 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Zhou‐Yan Bian's work include Cardiac Fibrosis and Remodeling (32 papers), Signaling Pathways in Disease (16 papers) and Peptidase Inhibition and Analysis (7 papers). Zhou‐Yan Bian is often cited by papers focused on Cardiac Fibrosis and Remodeling (32 papers), Signaling Pathways in Disease (16 papers) and Peptidase Inhibition and Analysis (7 papers). Zhou‐Yan Bian collaborates with scholars based in China, United States and Canada. Zhou‐Yan Bian's co-authors include Qizhu Tang, Hongliang Li, Ling Yan, Heng Zhou, Wei Deng, Jia Dai, Yuan Yuan, Zhi‐Gang She, Jing Zong and Lihua Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Zhou‐Yan Bian

63 papers receiving 2.2k citations

Peers

Countries citing papers authored by Zhou‐Yan Bian

Since Specialization

Citations

This map shows the geographic impact of Zhou‐Yan Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhou‐Yan Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhou‐Yan Bian more than expected).

Fields of papers citing papers by Zhou‐Yan Bian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhou‐Yan Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhou‐Yan Bian. The network helps show where Zhou‐Yan Bian may publish in the future.

Co-authorship network of co-authors of Zhou‐Yan Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Zhou‐Yan Bian. A scholar is included among the top collaborators of Zhou‐Yan Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhou‐Yan Bian. Zhou‐Yan Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study 2021 ·Frontiers in Pharmacology ·Qiang Wang, Haipeng Guo, Li Yu, Xiangdong Jian, Xinguo Hou, Ning Zhong, (unknown), (unknown), Zhou‐Yan Bian, Yi Zhang, Yingying Hu, Yan Sun, Xueyuan Yu, Yuan Li, Bei Jiang, Yan Li, (unknown), Yingying Wu, Yanxia Gao, Zhao Hu	10
2	Antithrombotic therapy and outcome in patients with ischemic cardiomyopathy complicated by left ventricular thrombus 2019 ·Jie Yan, Xiaoyang Zhou, Zhou‐Yan Bian, Si‐Chi Xu	1
3	Combined utilization of bisoprolol and glutathione attenuates ventricular remodeling of takotsubo cardiomyopathy in mice 2015 ·(unknown), Zhou‐Yan Bian, Heng Zhou, Wei Deng, Jinxiu Zhu	1
4	Puerarin attenuates the inflammatory response and apoptosis in LPS-stimulated cardiomyocytes 2015 ·Experimental and Therapeutic Medicine ·Yuan Yuan, Heng Zhou, Qingqing Wu, (unknown), Zhou‐Yan Bian, Wei Deng, (unknown), Qizhu Tang	34
5	Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial–mesenchymal transition 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yuan Liu, (unknown), Hai‐Han Liao, Wei Liu, Juan Liu, Zhen‐Guo Ma, Qingqing Wu, Man Xu, Ning Zhang, Yao Zhang, Zhou‐Yan Bian, Qizhu Tang	44
6	Naringenin attenuates pressure overload-induced cardiac hypertrophy 2015 ·Experimental and Therapeutic Medicine ·Ning Zhang, Zheng Yang, Yuan Yuan, Fangfang Li, Yuan Liu, Zhen‐Guo Ma, Hai‐Han Liao, Zhou‐Yan Bian, Yao Zhang, Heng Zhou, Wei Deng, (unknown), Qizhu Tang	44
7	Icariin protects H9c2 cardiomyocytes from lipopolysaccharide-induced injury via inhibition of the reactive oxygen species-dependent c-Jun N-terminal kinases/nuclear factor-κB pathway 2015 ·Molecular Medicine Reports ·Heng Zhou, Yuan Yuan, Yuan Liu, Jian Ni, Wei Deng, Zhou‐Yan Bian, Jia Dai, Qizhu Tang	24
8	Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential 2015 ·Molecular Medicine Reports ·Yuan Liu, (unknown), Zhen‐Guo Ma, Wei Liu, Qingqing Wu, Zheng Yang, Fangfang Li, Yuan Yuan, Zhou‐Yan Bian, Qizhu Tang	22
9	Shensongyangxin protects against pressure overload-induced cardiac hypertrophy 2015 ·Molecular Medicine Reports ·Zhi‐Gang She, Qingqing Wu, Jian Ni, Wei Deng, Cong Wei, Zhenhua Jia, Heng Zhou, (unknown), Zhou‐Yan Bian, Qizhu Tang	5
10	Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy. 2015 ·International Journal of Clinical and Experimental Pathology ·(unknown), Qingqing Wu, Yuan Liu, (unknown), Zhou‐Yan Bian, Qi‐Zhu Tang	29
11	Dickkopf-3 attenuates pressure overload-induced cardiac remodelling 2014 ·Cardiovascular Research ·Yan Zhang, Yu Liu, Xue‐Hai Zhu, Xiaodong Zhang, (unknown), Zhou‐Yan Bian, Xiaofei Zhang, Ke Chen, Xiang Wei, Lu Gao, Lihua Zhu, Qinglin Yang, Guo‐Chang Fan, Wayne Bond Lau, Xinliang Ma, Hongliang Li	65
12	ATF3 regulates multiple targets and may play a dual role in cardiac hypertrophy and injury 2014 ·International Journal of Cardiology ·Heng Zhou, Haipeng Guo, Jing Zong, Jia Dai, Yuan Yuan, Zhou‐Yan Bian, Qizhu Tang	26
13	Hesperetin protects against cardiac remodelling induced by pressure overload in mice 2013 ·Journal of Molecular Histology ·Wei Deng, (unknown), Yi Fang, Heng Zhou, Zhihong Cheng, (unknown), Rui Zhang, Jieyu Zhang, Peng Pu, Yuan Liu, Zhou‐Yan Bian, Qizhu Tang	41
14	NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload 2013 ·Laboratory Investigation ·Jing Zong, Mohamed Salim, Heng Zhou, Zhou‐Yan Bian, Jia Dai, Yuan Yuan, Wei Deng, Jieyu Zhang, Rui Zhang, Qingqing Wu, Qizhu Tang	34
15	HSP75 protects against cardiac hypertrophy and fibrosis 2011 ·Journal of Cellular Biochemistry ·Yan Zhang, Ding‐Sheng Jiang, Ling Yan, (unknown), Zhou‐Yan Bian, Guosheng Lin	22
16	Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR‐dependent signaling 2010 ·Journal of Cellular Biochemistry ·Wen Ai, Yan Zhang, Qi‐Zhu Tang, Ling Yan, Zhou‐Yan Bian, Chen Liu, He Huang, Xue Bai, Lu Yin, Hongliang Li	43
17	Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species‐dependent ERK1/2 signalling 2010 ·British Journal of Pharmacology ·Zhi‐Gang She, (unknown), Ling Yan, Yan Zhang, Lihua Zhu, Lang Wang, Chen Liu, Zhou‐Yan Bian, Hongliang Li	44
18	Change of cardiac function in experimental autoimmune myocarditis is correlated with the expression of annexin VI 2009 ·Acta Cardiologica ·Zhou‐Yan Bian, Qizhu Tang, Hui Wu, Ji Huang, Zhi‐Gang She	1
19	The effects of NK4 on viral myocarditis mice 2009 ·Cardiovascular Pathology ·Zhi‐Gang She, Qizhu Tang, Zhengrong Huang, Ying Chen, (unknown), Hui Wu, Ji Huang, (unknown), Ling Yan, Zhou‐Yan Bian	2
20	Crocetin protects against cardiac hypertrophy by blocking MEK‐ERK1/2 signalling pathway 2008 ·Journal of Cellular and Molecular Medicine ·Jun Cai, Fangfang Yi, Zhou‐Yan Bian, Zhi‐Gang She, Long Yang, Ling Yan, (unknown), Xinchun Yang, Hongliang Li	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact